| Literature DB >> 30913332 |
Brian E Young1, Nandini Kundu1, Jonathan T Sczepanski1.
Abstract
As chiral molecules, naturally occurring d-oligonucleotides have enantiomers, l-DNA and l-RNA, which are comprised of l-(deoxy)ribose sugars. These mirror-image oligonucleotides have the same physical and chemical properties as that of their native d-counterparts, yet are highly orthogonal to the stereospecific environment of biology. Consequently, l-oligonucleotides are resistant to nuclease degradation and many of the off-target interactions that plague traditional d-oligonucleotide-based technologies; thus making them ideal for biomedical applications. Despite a flurry of interest during the early 1990s, the inability of d- and l-oligonucleotides to form contiguous Watson-Crick base pairs with each other has ultimately led to the perception that l-oligonucleotides have only limited utility. Recently, however, scientists have begun to uncover novel strategies to harness the bio-orthogonality of l-oligonucleotides, while overcoming (and even exploiting) their inability to Watson-Crick base pair with the natural polymer. Herein, a brief history of l-oligonucleotide research is presented and emerging l-oligonucleotide-based technologies, as well as their applications in research and therapy, are presented.Entities:
Keywords: DNA; RNA; chirality; oligonucleotides; spiegelmers
Mesh:
Substances:
Year: 2019 PMID: 30913332 PMCID: PMC6615976 DOI: 10.1002/chem.201900149
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236